Offer - Urjas Oil for just ₹ 1 X
Metlong DS Tablet SR is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Diabetes.
The optimal dosage of Metlong DS Tablet SR is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Metlong DS Tablet SR include Stomach Upset, Difficulty urinating. Apart from the aforementioned side effects, Metlong DS Tablet SR can also lead to other problems, which have been listed below. Normally, these side effects of Metlong DS Tablet SR are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Metlong DS Tablet SR's effect is Mild during pregnancy and Moderate for lactating mothers. Warnings related to Metlong DS Tablet SR's effects on the liver, heart and kidney, if any, have been listed below.
Metlong DS Tablet SR is not recommended if you suffer from certain medical conditions as it can have adverse effects. Congestive Heart Failure (CHF), Anemia, Shock are examples of such conditions. The section on Metlong DS Tablet SR contraindications lists all such conditions.
Besides this, Metlong DS Tablet SR may also have severe interaction with some medicines. A complete list of these interactions is given below.
You should also be aware that Metlong DS Tablet SR is safe while driving, and is addiction.
Metlong DS Tablet SR is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Metlong DS Tablet SR safe for pregnant women?
Metlong has little to no side effects in pregnant women.
Is the use of Metlong DS Tablet SR safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Metlong. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Metlong DS Tablet SR on the Kidneys?
Using Metlong does not have any harmful effects on kidneys.
What is the effect of Metlong DS Tablet SR on the Liver?
Metlong is completely safe for the liver.
What is the effect of Metlong DS Tablet SR on the Heart?
Metlong is not harmful for the heart.
Metlong DS Tablet SR should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Metlong DS Tablet SR unless your doctor advises you to do so -
Is this Metlong DS Tablet SR habit forming or addictive?
Forming a habit of Metlong DS Tablet SR has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Metlong DS Tablet SR since it will not make you feel sleepy.
Is it safe?
Metlong DS Tablet SR should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Metlong DS Tablet SR for mental disorders.
Interaction between Food and Metlong DS Tablet SR
There is no information on the effects of taking Metlong DS Tablet SR with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Metlong DS Tablet SR
Taking Metlong DS Tablet SR with alcohol can have severely harmful effects on your health.
Metlong helps in weight loss by reducing appetite and food intake. It also increases the insulin sensitivity in your body to work more effectively. This lead to decreased glucose production increases the use of glucose and decrease the fat deposition further helps in weight loss. However, Metlong is not approved for weight loss, this is an off-label use.
Yes, Metlong can cause low blood sugar (hypoglycemia). However, this can also occur if you delay or miss a meal, drink alcohol, exercise more than usual, can't eat due to stomach upset, and taking other antidiabetic medicine with metformin. So, regular monitoring of blood glucose level is needed and be cautious of symptoms of hypoglycemia, always keep glucose-rich food with you.
Yes, you can take Metlong with a beta-blocker. People with diabetes tend to develop heart disease or stroke at an earlier age than the general population. One reason for this is that high glucose levels increase your risk of high blood pressure (hypertension). No harmful interactions are seen between them. However, a recent study suggests that beta-blockers can decrease the plasma level of Metlong and long-term use can increase lactic acid and uric acid in the blood.
Lactic acidosis associated with Metlong treatment is a rare but fatal adverse effect. Lactic acidosis appears to result from biguanide interference causing an increase in production and decrease in clearance of lactate leading to higher cellular lactate levels. A decrease in pyruvate carboxylase activity, the rate-limiting enzyme in the formation of glucose from lactate, can also decrease hepatic metabolism of lactate. leading to increasing lactic acidosis. Signs and symptoms of Metlong induced lactic acidosis are nonspecific and include anorexia, nausea, vomiting, altered level of consciousness, hyperpnoea, abdominal pain, and thirst.
Metlong can be taken forever, diabetes is a progressive disease it's possible that more medication and/or insulin may eventually need to be added to the regime.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826